What types of local or European grants are available for life sciences start-ups? What do you do when it is too late for Venture Capital and too early for Private Equity? What is the best financing strategy when transitioning from a bio-incubator into your own facilities? Are you aware of the existing tax incentives to optimise your business plan?
There are so many questions about the best funding & financing strategies from start-up to scale-up and beyond.
Attending this one-day event, you will hear from experts and experienced entrepreneurs about the current state of funding options for life sciences companies and how to optimise your business plan along the way. In the afternoon you will have the possibility to ask the experts tailormade advice in one-on-one meetings on all aspects related to funding and business plan optimisation.
Pascale Engelen - Co General Manager flanders.bio
Elise Carton - Senior Consultant Valuation Services, PwC
Tom Wallyn - Director Tax Services, PwC
Intro by Katrien Vanherck - Business Consultant, CMAST: "How grants can complement your financial plan in an early stage"
Testimonial by Ann Beliën - CEO, Rejuvenate Biomed
Intro by Patrick Van Beneden - Partner, GIMV
Testimonial by Mark Vaeck - CEO, Complix
Intro by Sandra Cauwenberghs - Senior Financial Analyst, Pharma & Biotech, KBC Securities
Testimonial - TBD
Moderated by Dirk Reyn - Vice Chairman Board of Directors, flanders.bio
Participants can sign up for a meeting with the experts of the presenting strategic partners. Please send your request for a meeting with your specific question to email@example.com (after registration).
Meetings will be scheduled in blocks of 20 minutes each. You will receive your meeting schedule before the event.
A business lounge is at your disposal if you are participating in this session.
Jozef Mertensstraat 140
flanders.bio members: EUR 40*
non-flanders.bio members: EUR 80*